Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS by Samit Ghosal, Binayak Sinha

“…We saw publication of the first 2 randomized trials with gliptins published a year and a half back. On the face value SAVOR TIMI and EXAMINE satisfied the primary composite CV end-points. …”
Get full text